Artificial intelligence-powered software platform for aneurysms, pulmonary embolisms, and strokes

Comprehensive Product Suite

RapidAI offers a range of specialized solutions for stroke, aneurysm, and pulmonary embolism diagnosis and treatment. The platform also provides analytics and clinical trial solutions, enhancing its versatility in medical imaging.

Extensive Services and Training

RapidAI provides robust implementation and technical support, along with a dedicated learning platform called Rapid U. This includes on-demand learning, instructor-led training, and CE credits, ensuring users can maximize the platform's potential.

Advanced Integration Capabilities

The platform offers advanced services such as EMR integration, workflow optimization, and custom insights, allowing seamless incorporation into existing healthcare systems and processes.

Rich Resource Library

RapidAI maintains a comprehensive resource section, including Rapid Hero Stories, publications, reimbursement information, clinical trials data, and a regularly updated blog, providing valuable insights for users.

Award-Winning Technology

RapidAI's innovative approach has earned recognition, including the MedTech Breakthrough Award for Best New Imaging Solution in May 2023 and a place on CB Insights' Digital Health 50 List in December 2023.

Global Support Network

The platform offers customer support across multiple countries, including the United States, UK, France, Brazil, Australia, and Japan, ensuring worldwide accessibility and assistance.

What are the key benefits of using RapidAI?

RapidAI offers several key benefits:

• Faster and more accurate triage and transfer decisions
• Accelerated process for finding, tracking, and treating aneurysms
• Quick detection of suspected pulmonary embolism cases
• Enhanced clinical depth in AI-powered clinical decision support (CDS) software

How widespread is the use of RapidAI?

RapidAI has a significant global presence:

• Used by 2,200 hospitals worldwide
• Has impacted 90 million lives
• Offers support in multiple countries including the US, UK, France, Brazil, Australia, and Japan

What recent achievements has RapidAI accomplished?

RapidAI has recently achieved several milestones:

• Won the MedTech Breakthrough Award for Best New Imaging Solution in May 2023
• Named to CB Insights' Digital Health 50 List in December 2023
• Received a $75 Million Growth Investment in July 2023

What types of medical conditions does RapidAI specialize in?

RapidAI specializes in AI-powered imaging solutions for:

• Strokes
• Aneurysms
• Pulmonary Embolisms

How does RapidAI support ongoing learning and development?

RapidAI offers a comprehensive learning platform called Rapid U, which includes:

• On-demand learning resources
• Instructor-led training sessions
• Continuing Education (CE) credits for healthcare professionals